These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 29792732)

  • 1. Phosphatidylinositol 3-kinase β and δ isoforms play key roles in metastasis of prostate cancer DU145 cells.
    Zhang Z; Liu J; Wang Y; Tan X; Zhao W; Xing X; Qiu Y; Wang R; Jin M; Fan G; Zhang P; Zhong Y; Kong D
    FASEB J; 2018 Nov; 32(11):5967-5975. PubMed ID: 29792732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3Kδ and PI3Kγ isoforms have distinct functions in regulating pro-tumoural signalling in the multiple myeloma microenvironment.
    Piddock RE; Loughran N; Marlein CR; Robinson SD; Edwards DR; Yu S; Pillinger GE; Zhou Z; Zaitseva L; Auger MJ; Rushworth SA; Bowles KM
    Blood Cancer J; 2017 Mar; 7(3):e539. PubMed ID: 28282033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro and In Vivo Antimetastatic Effects of ZSTK474 on Prostate Cancer DU145 Cells.
    Liu J; Tan X; Zhao W; Liu J; Xing X; Fan G; Zhang P; Zhang Z; Zhong Y; Kong D
    Curr Cancer Drug Targets; 2019; 19(4):321-329. PubMed ID: 30205797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors.
    Ma CC; Zhang CM; Tang LQ; Liu ZP
    Eur J Med Chem; 2018 May; 151():9-17. PubMed ID: 29601991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isoform-selective phosphatidylinositol 3-kinase inhibitors on osteoclasts: actions on cytoskeletal organization, survival, and resorption.
    Shugg RP; Thomson A; Tanabe N; Kashishian A; Steiner BH; Puri KD; Pereverzev A; Lannutti BJ; Jirik FR; Dixon SJ; Sims SM
    J Biol Chem; 2013 Dec; 288(49):35346-57. PubMed ID: 24133210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of upregulated phosphoinositide 3-kinase γ as a target to suppress breast cancer cell migration and invasion.
    Xie Y; Abel PW; Kirui JK; Deng C; Sharma P; Wolff DW; Toews ML; Tu Y
    Biochem Pharmacol; 2013 May; 85(10):1454-62. PubMed ID: 23500535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacological model reveals biased dependency on PI3K isoforms for tumor cell growth.
    Wang X; Li JP; Yang Y; Ding J; Meng LH
    Acta Pharmacol Sin; 2013 Sep; 34(9):1201-7. PubMed ID: 23892273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting PI3Kδ and PI3Kγ signalling disrupts human AML survival and bone marrow stromal cell mediated protection.
    Pillinger G; Loughran NV; Piddock RE; Shafat MS; Zaitseva L; Abdul-Aziz A; Lawes MJ; Bowles KM; Rushworth SA
    Oncotarget; 2016 Jun; 7(26):39784-39795. PubMed ID: 27174919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration.
    Ali AY; Wu X; Eissa N; Hou S; Ghia JE; Murooka TT; Banerji V; Johnston JB; Lin F; Gibson SB; Marshall AJ
    Leukemia; 2018 Sep; 32(9):1958-1969. PubMed ID: 29479062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-inflammation effects of naloxone involve phosphoinositide 3-kinase delta and gamma.
    Wang TY; Su NY; Shih PC; Tsai PS; Huang CJ
    J Surg Res; 2014 Dec; 192(2):599-606. PubMed ID: 25016442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival.
    Juss JK; Hayhoe RP; Owen CE; Bruce I; Walmsley SR; Cowburn AS; Kulkarni S; Boyle KB; Stephens L; Hawkins PT; Chilvers ER; Condliffe AM
    PLoS One; 2012; 7(9):e45933. PubMed ID: 23029326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphoinositide 3-kinase β, phosphoinositide 3-kinase δ, and phosphoinositide 3-kinase γ mediate the anti-inflammatory effects of magnesium sulfate.
    Lee PY; Yang CH; Kao MC; Su NY; Tsai PS; Huang CJ
    J Surg Res; 2015 Aug; 197(2):390-7. PubMed ID: 25972311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of PI3Kγ and δ Inhibitors for Inflammatory and Autoimmune Diseases.
    Perry MWD; Abdulai R; Mogemark M; Petersen J; Thomas MJ; Valastro B; Westin Eriksson A
    J Med Chem; 2019 May; 62(10):4783-4814. PubMed ID: 30582813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a novel p110β-specific inhibitor BL140 that overcomes MDV3100-resistance in castration-resistant prostate cancer cells.
    He C; Duan S; Dong L; Wang Y; Hu Q; Liu C; Forrest ML; Holzbeierlein JM; Han S; Li B
    Prostate; 2017 Aug; 77(11):1187-1198. PubMed ID: 28631436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.
    Kimbrough-Allah MN; Millena AC; Khan SA
    Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Phosphatidylinositol 3-Kinase Activity in Regulatory T Cells Leads to Neuronal Inflammation.
    Stark AK; Davenport ECM; Patton DT; Scudamore CL; Vanhaesebroeck B; Veldhoen M; Garden OA; Okkenhaug K
    J Immunol; 2020 Jul; 205(1):78-89. PubMed ID: 32414808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.
    Ye J; Gao M; Guo X; Zhang H; Jiang F
    Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-Driven PI3K-AKT Signaling in the Hepatocyte Is Mediated by Redundant PI3Kα and PI3Kβ Activities and Is Promoted by RAS.
    Molinaro A; Becattini B; Mazzoli A; Bleve A; Radici L; Maxvall I; Sopasakis VR; Molinaro A; Bäckhed F; Solinas G
    Cell Metab; 2019 Jun; 29(6):1400-1409.e5. PubMed ID: 30982732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy.
    Collmann E; Bohnacker T; Marone R; Dawson J; Rehberg M; Stringer R; Krombach F; Burkhart C; Hirsch E; Hollingworth GJ; Thomas M; Wymann MP
    J Allergy Clin Immunol; 2013 Oct; 132(4):959-68. PubMed ID: 23683463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PI3Kgamma is the dominant isoform involved in migratory responses of human T lymphocytes: effects of ex vivo maintenance and limitations of non-viral delivery of siRNA.
    Smith LD; Hickman ES; Parry RV; Westwick J; Ward SG
    Cell Signal; 2007 Dec; 19(12):2528-39. PubMed ID: 17900864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.